Stockreport

aTyr Pharma Announces Publication in the Journal Cellular and Molecular Immunology

Ethos Technologies Inc. - Class A  (LIFE) 
Last ethos technologies inc. - class a earnings: 3/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: atyrpharma.com/investors-media
PDF Paper highlights the essential role that histidyl tRNA synthetase (HARS) plays in immune responses in a broad range of inflammatory disease states Lead therapeutic cand [Read more]